144 related articles for article (PubMed ID: 21962322)
1. Contraindications to pharmacologic therapies for gout.
Lewis DA; Herrington WG
Am J Med; 2011 Oct; 124(10):e15. PubMed ID: 21962322
[No Abstract] [Full Text] [Related]
2. Steroid for gout: myth or elixir?
Chao CT
Am J Med; 2011 Oct; 124(10):e17; author reply e19. PubMed ID: 21962323
[No Abstract] [Full Text] [Related]
3. Prevalence of contraindications and prescription of pharmacologic therapies for gout.
Keenan RT; O'Brien WR; Lee KH; Crittenden DB; Fisher MC; Goldfarb DS; Krasnokutsky S; Oh C; Pillinger MH
Am J Med; 2011 Feb; 124(2):155-63. PubMed ID: 21295195
[TBL] [Abstract][Full Text] [Related]
4. [Chronic gout. Case report of a severe course of disease].
Boxberger F; Harsch IA; Brueckl WM; Hautmann M; Baum U; Hahn EG; Wein A
Med Klin (Munich); 2003 Nov; 98(11):646-7. PubMed ID: 14631540
[No Abstract] [Full Text] [Related]
5. [Hyperuricemia. When and how to treat?].
Reuss-Borst MA
Internist (Berl); 2016 Feb; 57(2):194-201. PubMed ID: 26791735
[TBL] [Abstract][Full Text] [Related]
6. [Hyperuricemia and gout--treatment].
Gröbner W; Walter-Sack I
Dtsch Med Wochenschr; 2002 Feb; 127(5):210-3. PubMed ID: 11821994
[No Abstract] [Full Text] [Related]
7. On call. I've had gout for many years. I used to take Zyloprim without any problems, but I just had a severe allergic reaction, so my doctor switched me to Benemid. I'm doing okay, but the drug sometimes upsets my stomach. Do you have any suggestions?
Simon HB
Harv Mens Health Watch; 2010 Jan; 14(6):7-8. PubMed ID: 20464796
[No Abstract] [Full Text] [Related]
8. Management of gout.
Fox IH; Kelley WN
JAMA; 1979 Jul; 242(4):361-4. PubMed ID: 448944
[No Abstract] [Full Text] [Related]
9. Stopping progression to tophaceous gout. When and how to use urate-lowering therapy.
McDonald E; Marino C
Postgrad Med; 1998 Dec; 104(6):117-20, 123-4, 127. PubMed ID: 9861261
[TBL] [Abstract][Full Text] [Related]
10. Gout in women.
McClory J; Said N
Med Health R I; 2009 Nov; 92(11):363-4, 368. PubMed ID: 19999895
[No Abstract] [Full Text] [Related]
11. Guideline development for the management of gout: role of combination therapy with a focus on lesinurad.
Jones G; Panova E; Day R
Drug Des Devel Ther; 2017; 11():3077-3081. PubMed ID: 29123379
[TBL] [Abstract][Full Text] [Related]
12. Gout.
Rott KT; Agudelo CA
JAMA; 2003 Jun; 289(21):2857-60. PubMed ID: 12783917
[No Abstract] [Full Text] [Related]
13. Verinurad combined with febuxostat in Japanese adults with gout or asymptomatic hyperuricaemia: a phase 2a, open-label study.
Shiramoto M; Liu S; Shen Z; Yan X; Yamamoto A; Gillen M; Ito Y; Hall J
Rheumatology (Oxford); 2018 Sep; 57(9):1602-1610. PubMed ID: 29868853
[TBL] [Abstract][Full Text] [Related]
14. A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300-600 mg/day versus benzbromarone 100-200 mg/day in patients with gout.
Reinders MK; Haagsma C; Jansen TL; van Roon EN; Delsing J; van de Laar MA; Brouwers JR
Ann Rheum Dis; 2009 Jun; 68(6):892-7. PubMed ID: 18633127
[TBL] [Abstract][Full Text] [Related]
15. Gout: a comprehensive review.
Rymal E; Rizzolo D
JAAPA; 2014 Sep; 27(9):26-31. PubMed ID: 25102078
[TBL] [Abstract][Full Text] [Related]
16. Gout and hyperuricemia.
Chilappa CS; Aronow WS; Shapiro D; Sperber K; Patel U; Ash JY
Compr Ther; 2010; 36():3-13. PubMed ID: 21229813
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of combined low dose of Allopurinol and benzbromarone compared to standard dose of Allopurinol in hyperuricemia.
Akkasilpa S; Osiri M; Deesomchok U; Avihingsanon Y
J Med Assoc Thai; 2004 Sep; 87(9):1087-91. PubMed ID: 15516011
[TBL] [Abstract][Full Text] [Related]
18. [How to select and use urate lowering agents for hyperuricemia].
Yamanaka H
Nihon Rinsho; 1996 Dec; 54(12):3261-5. PubMed ID: 8976102
[TBL] [Abstract][Full Text] [Related]
19. [Uricosuric agents in the treatment of gout].
Fabregoule M; Catanzariti L
Lille Med; 1970 Jan; 15(1):266-8. PubMed ID: 5440984
[No Abstract] [Full Text] [Related]
20. [Hyperuricemia and gout : New aspects of an old disease].
Witt M; Schulze-Koops H
Internist (Berl); 2016 Jul; 57(7):656-65. PubMed ID: 27286837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
